Free Trial
LON:AVO

Advanced Oncotherapy (AVO) Share Price, News & Analysis

GBX 1.75
-0.18 (-9.09%)
(As of 08/30/2023)
Today's Range
1.75
1.75
50-Day Range
1.75
1.75
52-Week Range
1.75
25.75
Volume
200,000 shs
Average Volume
1.27 million shs
Market Capitalization
£9.49 million
P/E Ratio
N/A
Dividend Yield
5.49%
Price Target
N/A
AVO stock logo

About Advanced Oncotherapy Stock (LON:AVO)

Advanced Oncotherapy plc, together with its subsidiaries, engages in designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.

AVO Stock Price History

AVO Stock News Headlines

Advanced Oncotherapy Share Chat
Advanced Oncotherapy PLC AVO
[URGENT] Altcoin Winning Picks
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
[URGENT] Altcoin Winning Picks
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
Advanced Oncotherapy raises £2mln at a premium
See More Headlines
Receive AVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Advanced Oncotherapy and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
6/29/2020
Today
7/18/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
174
Year Founded
N/A

Profitability

Net Income
£-32,600,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
GBX 0.05 per share
Book Value
GBX 14 per share

Miscellaneous

Free Float
N/A
Market Cap
£9.49 million
Optionable
Not Optionable
Beta
0.06
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Dr. Michael Jeffrey Sinclair (Age 82)
    Executive Chairman
    Comp: $434.42k
  • Mr. Nicolas Serandour (Age 49)
    CEO & Executive Director
    Comp: $502.96k
  • Prof. Stephen Myers OBE (Age 78)
    Executive Director
    Comp: $397.72k
  • Mr. Ed Lee
    COO & President of Europe
  • Mr. Graham Pughe
    Senior Vice-President of Accounting
  • Ms. Berengere Pons-Chabord
    Senior Vice-President of Corporate Finance
  • Mr. David Navas
    Vice President of Investor and Public Relations
  • Ms. Bridget Biggar
    Director of Human Resources
  • Ms. Donatella Ungaro
    Managing Director of ADAM
  • Ms. Marina Giunta
    Head of Physics Group

AVO Stock Analysis - Frequently Asked Questions

How have AVO shares performed this year?

Advanced Oncotherapy's stock was trading at GBX 1.75 at the beginning of the year. Since then, AVO stock has increased by 0.0% and is now trading at GBX 1.75.
View the best growth stocks for 2024 here
.

How were Advanced Oncotherapy's earnings last quarter?

Advanced Oncotherapy plc (LON:AVO) posted its quarterly earnings data on Monday, June, 29th. The company reported ($9.83) earnings per share for the quarter, missing the consensus estimate of ($8.90) by $0.93.

How do I buy shares of Advanced Oncotherapy?

Shares of AVO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Advanced Oncotherapy own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Advanced Oncotherapy investors own include UK Oil & Gas (UKOG), Oxford Biomedica (OXB), BMR Group (BMR), GW Pharmaceuticals (GWPH), Lancashire (LRE) and Sirius Minerals (SXX).

This page (LON:AVO) was last updated on 7/18/2024 by MarketBeat.com Staff

From Our Partners